News
Medicines derived from living cells — biologics — are some of the most expensive medicines in America. What keeps prices ...
Uncoordinated price cuts across the EU are contributing to medicine shortages and driving manufacturers towards more ...
The amended product information will provide more specific detail on encephalitis as a known adverse reaction to ...
The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...
In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...
Novo Nordisk A/S (NYSE:NVO) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On June 23, Novo Nordisk A ...
Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Non-Tech Stocks to Buy and Hold For 3 Years. On July 3, Janssen-Cilag, a ...
Denmark's Novo Nordisk said on Tuesday it had submitted a new, higher dose of its obesity treatment Wegovy to the European Medicines Agency for approval, with one in three trial participants achieving ...
FXS is a Common Inherited Form of Autism EMA Designation Offers People with FXS Throughout European Union Access to Novel Therapeutic LOS ANGELES, July 7, 2025 /PRNewswire/ -- Spinogenix, Inc., a ...
Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of patients worldwide, today announced that the ...
REYKJAVIK, Iceland and LONDON, June 23, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
European Medicines Agency CHMP Recommends EU Approval of Partner Therapeutics IMREPLYS® (sargramostim, rhu GM-CSF) to Treat Exposure to Myelosuppressive Doses of Radiation (Haematopoietic Sub ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results